Ozempic

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012.Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

Read more in the app

Ozempic changed obesity treatment, but experts say the real revolution is next

Ozempic and Wegovy linked to surprising drop in violent behavior

Most people who stop GLP-1 drugs like Ozempic eventually return

Semaglutide (Ozempic) linked to fewer bone fractures despite greater weight loss

Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk

People taking GLP-1 weight loss drugs like Ozempic started moving less

Ozempic, GPL-1s may help curb substance use disorders, UTEP study finds - EurekAlert!

Scientists discover why ozempic may not work for some people

This new diabetes pill burns fat without the downsides of Ozempic

Scientists Finally Uncover Why Ozempic Stops Working for Some People

People Who Stop Ozempic Often Don’t Gain the Weight Back

Scientists discover why Ozempic and Wegovy weight loss eventually plateaus

Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk

People who lost the most weight on Ozempic saw huge health benefits

New ways to keep from losing muscle on Ozempic

Ozempic delivers major weight loss in adults over 65, study finds

Scientists discover why Ozempic works better for some people

Weight-Loss Drugs Like Ozempic May Come With an Unexpected Cost

The dark side of weight loss drugs: Ozempic's surprising hidden cost

Weight loss drug Ozempic linked to lower depression and anxiety risk

Quantum Worlds »